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i n d i a n h e a r t j o u r n a l 6 5 ( 2 0 1 3 ) 6 2 9e6 3 5632treatment for various malignancies. However, most of the
cancer chemotherapeutic agents are associated with sig-
nificant side-effects which often nullify the gains achieved in
terms of improved cancer outcomes. Cardiotoxicity is one of
the most important complications of cancer chemotherapy
and may be associated with significant morbidity and mor-
tality. Anthracyclines and monoclonal antibody-based tyro-
sine kinase inhibitors are the two agents most notorious for
causing cardiotoxicity.
Several different approaches are being evaluated for
preventing development of cancer chemotherapy-related
cardiotoxicity. Thorough pre-treatment cardiac evaluation
to identify patients with pre-existing cardiac diseases or
those at risk of developing cardiotoxicity and limiting the
maximum dose of the potentially cardiotoxic agents are
very helpful in reducing the likelihood of cardiotoxicity
associated with cancer treatment. Nonetheless, cardiotox-
icity can develop even in patients without pre-existing
cardiac illness and is not always dose-dependent, thus
limiting our ability to prevent cardiotoxicity with reason-
able certainty. Consequently, several alternative
approaches are being evaluated to prevent cancer
chemotherapy-related cardiotoxicity. Animal experiments
and initial human studies, most of which were non-
randomized, have shown that many of the cardiac drugs
such as angiotensin converting enzyme inhibitors (ACEI),
beta blockers and statins may be helpful in preventive
cardiotoxicity with cancer drugs. To this effect, the present
study by Bosch et al represents a well-performed random-
ized trial, which showed that a combination of enalapril (an
ACEI) and carvedilol (a beta blocker) was effective in
preventing development of LV systolic dysfunction in
patients receiving intensive chemotherapy for hemato-
logical malignancies. The therapy was also effective in
improving clinical outcomes in this patient population. The
reason why patients undergoing HSCT did not derive much
benefit was related to the fact that they did not receive
prolonged chemotherapeutic treatment and were therefore
at low risk of having cardiotoxicity. A strong point of the
study was that the changes in LVEF were assessed by both
echocardiography and cardiac MRI, which improved the
reliability of the study findings. However, the major limi-
tation of the study was its small sample size. In addition,
the magnitude of the benefit observed in this study was
small, in part because of the fact that only the patients with
normal LVEF and no cardiac illness at baseline were
included. Thus, while this study has shown encouraging
findings, larger studies are required to confirm these find-
ings and to also assess role of these agents in preventing
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their components originating from the oral cavity or respira-
tory tract, have been suggested to contribute to inflammation
in the coronary plaque, leading to rupture and the subsequent
development of coronary thrombus. We aimed to measure
bacterial DNA in thrombus aspirates of patients with ST-seg-
ment-elevation myocardial infarction and to check for a pos-
sible association between bacteria findings and oral pathology
in the same cohort.
Methods and results: Thrombus aspirates and arterial
blood from patients with ST-segment-elevation myocardial
infarction undergoing primary percutaneous coronary inter-
vention (n ¼ 101; 76% male; mean age, 63.3 years) were ana-
lyzed with real-time quantitative polymerase chain reaction
with specific primers and probes to detect bacterial DNA from
several oral species and Chlamydia pneumoniae. The median
value for the total amount of bacterial DNA in thrombi was 16
times higher than that found in their blood samples. Bacterial
DNA typical for endodontic infection, mainly oral viridans
streptococci, was measured in 78.2% of thrombi, and perio-
dontal pathogens were measured in 34.7%. Bacteria-like
structures were detected by transmission electron micro-
scopy in all 9 thrombus samples analyzed; whole bacteria
were detected in 3 of 9 cases. Monocyte/macrophage markers
for bacteria recognition (CD14) and inflammation (CD68) were
detected in thrombi (8 of 8) by immunohistochemistry. Among
the subgroup of 30 patients with myocardial infarction
examined by panoramic tomography, a significant association
between the presence of periapical abscesses and oral vir-
idans streptococci DNA-positive thrombi was found (odds
ratio, 13.2; 95% confidence interval, 2.11e82.5; p ¼ 0.004).
Conclusions: Dental infection and oral bacteria, especially
viridans streptococci, may be associated with the develop-
ment of acute coronary thrombosis.
1. Perspective
Poor dental hygiene has been linked to an increased risk of
cardiovascular diseases. A recent meta-analysis1 and a recent
large population study2 have shown a correlation between
coronary artery disease and dental health like alveolar bone
loss, pathological periodontal pockets and missing teeth.
However, there was no consensus on the most pathologically
relevant bacteria.
This study demonstrated that oral bacterial DNA, espe-
cially oral viridans streptococci, can be detected in the coro-
nary thrombus aspirates of patients with ST-elevation MI
undergoing primary PCI. Bacteria-like structures and compo-
nents were detected by transmission electronmicroscopy and
monocyte/macrophage markers for bacteria recognition
i n d i a n h e a r t j o u rn a l 6 5 ( 2 0 1 3 ) 6 2 9e6 3 5 633(CD14) and inflammation (CD 68) in thrombus aspirates by
immunohistochemistry.
Oral streptococci have several characteristics that may
either induce or maintain the atherosclerotic process: 1) they
are able to attach to different surfaces and generate a biofilm
enabling bacteria to infiltrate the tissue 2) they are capable of
invading coronary endothelial cells and trigger the production
of inflammatory cytokines and monocyte chemoattractant
proteins 3) they also have thrombogenic properties and also
initiate platelet aggregation in atherosclerotic plaques. A sur-
face protein of one of these species of bacteria has been found
to bind to the fibrinogen receptor of platelets. These findings
suggest that oral viridans streptococci may be more than
innocent bystanders with an affinity for inflammatory envi-
ronments. The detection of DNA specific to oral pathogens
together with costimulation of monocyteemacrophage recep-
tors CD14 and CD 68 in thrombus aspirates suggests that these
pathogens disseminate into systemic circulation, migrate to
coronary plaques and cause or maintain inflammation.
The oral cavity containsw1000 species, of the streptococci,
Streptococcus sanguis and Streptococcus gordonii, detected in this
study using streptococcal virulence factors gtf P&G, can be
found only in the oral cavity.
The most common procedures associated with transient
bacteremia were root canal treatments and treatment for
periapical abscess. It has been hypothesized that repeated
transient bacteremias after such dental proceduresmay cause
an accumulation of pathogens in atherosclerotic plaques,
which may act to boost the inflammatory process and to
maintain low-grade inflammation.
This study also showed a very significant finding that there
was an inverse association between the number of stenotic
vessels and dental abscess and bacteria suggesting that dental
infection and bacteremia are not linked with coronary
stenosis but with the rupture of vulnerable plaques only.
In my opinion, the findings of the present study points to
the fact that poor dental hygiene is linked to increase in
atherosclerotic events like AMI most probably via increased
inflammation and rupture of the vulnerable plaque. The
detection of not only inflammatory markers but also bacteria
and their DNA components point to a direct role rather than
only a co-incidence. This calls for improvement in oral and
dental hygiene, in addition to control of conventional risk
factors for CAD, especially in our country where there is
increased incidence of bad habits like chewing of tobacco,
betel nuts and very poor oral hygiene. Moreover, prophylactic
antibiotics before any dental procedure should be advocated
not only to reduce infective endocarditis but also the risk of
future coronary events.r e f e r e n c e s
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Background: Occupational health hazards associated with
fluoroscopic-based procedures are well known, including a
high prevalence of orthopedic problems and those related to
radiation exposure, particularly cancer and cataracts. This
article reports the “first-in-man” clinical experience with a
novel radiation protection system designed to eliminate
radiation exposure to operators and thereby obviate the
need for orthopedically burdensome leaded aprons. The
Trinity Radiation Protection System consists of a combination
of fixed shields, radiation drapes, and interconnecting flexible
radiation resistant materials creating a complete radiation
protection environment for the operators, yetmaintaining full
and unimpeded contact with the patient and total control of
all operational elements of the catheterization equipment.
Methods and results: This report constitutes an analysis of
19 nonrandomized cases in which operator radiation expo-
sure data were collected (Trinity Radiation Protection System
n¼ 10 cases versus standard shielding alone n¼ 9). In all cases
performed with the Trinity System, there was neither any
measurable significant radiation exposure in any anatomic
region nor for the total case, whereas operators performing
cases with standard shielding were exposed to radiation in all
regions of their bodies (total per case exposure differences
p < 0.0001).
Conclusion: The novel radiation protection system
described is the first to provide a complete radiation barrier
that eliminates radiation exposure to operators, thereby
obviating the need for orthopedically burdensome leaded
aprons. This approach to radiation protection has promise to
enhance the safety and occupational health of medical per-
sonnel in the catheterization laboratory. ª 2012 Wiley Peri-
odicals, Inc.1. Perspective
The modern era of fluoroscopically guided interventional
procedures has resulted in dramatic increase in X-ray radia-
tion exposure to both physicians and cath lab staff. Reports of
radiation-induced cataracts, dermatitis, hematological
malignancies and brain tumors have been reported in inter-
ventionists because of cumulative radiation dose. Recently
